In this Section |
268977 Variations in drug specificity in US death certificate data for drug poisoning mortality surveillance, National Vital Statistics System, 2008-2009Tuesday, October 30, 2012
There are over 2,000 death investigation jurisdictions in the US. Death investigations procedures and reporting for drug deaths may vary among these jurisdictions. This research uses the National Vital Statistics System multiple cause of death (NVSS-MCOD) data to examine the variation in the specificity of drugs involved in drug poisoning deaths by jurisdictional factors. Using 2008-2009 NVSS-MCOD files drug poisoning deaths were defined as having ICD-10 underlying cause of death: X40-X44, X60-X64, X85, Y10-Y14. Among drug poisoning deaths, deaths with only non-specified drug(s) involved were defined as those with T50.9 and no MCOD in the range T36-T50.8. The proportion of drug poisoning deaths in which the drug involved was not specified were calculated for factors related to jurisdiction, including state, centralized medical examiner, and urbanization. In the US, for 25% of drug poisoning deaths the drug(s) involved were not specified. In 5 states, the drug involved was not specified in over 50% of drug poisoning deaths. In the 15 states and District of Columbia with state-wide medical examiners, the drug was not specified in 9% of the deaths. For jurisdictions with state-wide ME, only 3 states had more than 10% of deaths with drug not specified. Large metropolitan areas had a lower percentage with unspecified drugs. Variations by state and other jurisdictional factors in reporting the specificity of drugs involved needs to be considered when presenting rates of drug poisoning deaths for specific drugs. Medical examiners and coroners should review and standardize their investigation and reporting methods.
Learning Areas:
EpidemiologyPublic health or related laws, regulations, standards, or guidelines Public health or related organizational policy, standards, or other guidelines Public health or related research Learning Objectives: Keywords: Drug Abuse, Surveillance
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am an injury epidemiologist with over 15 years experience and have multiple peer reviewed publications in the field.
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4171.0: Data and Methods posters
|